جاهز للتشغيل
جاهز للتشغيل
Almost one million bottles of heart and kidney medications, including Corlanor and Sensipar, have been voluntarily recalled nationwide due to the presence of unexpected foreign matter on the tablet surfaces. The recall, conducted by Amgen, affects products distributed between late 2021 and late 2025 and is classified as a Class II FDA recall, indicating a potential for temporary or reversible health effects. The hazard has been deemed low, with no reported complaints.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading